Holding(s) in Company | 10-Nov-2023 | 10:14 | RNS |
Grant of Options and PDMR Dealing | 07-Nov-2023 | 16:11 | RNS |
Investor Presentation via Investor Meet Company | 19-Oct-2023 | 07:00 | RNS |
Update on Strategy & Changes to the Board | 12-Oct-2023 | 07:00 | RNS |
Board Changes | 01-Aug-2023 | 07:00 | RNS |
Corrected unaudited interim results to 31 May 2022 | 14-Jul-2023 | 14:00 | RNS |
Appointment of new leadership team & board changes | 12-Jul-2023 | 07:00 | RNS |
Change of registered office | 26-Jun-2023 | 11:10 | RNS |
Transition of Executive Leadership | 23-Jun-2023 | 07:00 | RNS |
Correction to interim results | 15-Jun-2023 | 17:16 | RNS |
Holding(s) in Company | 13-Jun-2023 | 07:45 | RNS |
Director/PDMR Shareholding | 05-Jun-2023 | 16:02 | RNS |
Interim Results | 31-May-2023 | 07:00 | RNS |
Sale of Oncimmune Limited to Freenome | 22-May-2023 | 07:00 | RNS |
Holding(s) in Company | 03-Apr-2023 | 16:38 | RNS |
Currency | UK Pounds |
Share Price | 23.00p |
Change Today | -1.10p |
% Change | -4.56 % |
52 Week High | 40.40 |
52 Week Low | 15.10 |
Volume | 37,641 |
Shares Issued | 74.14m |
Market Cap | £17.05m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:12 | 27,531 @ 25.40p |
14:12 | 10,000 @ 25.40p |
10:41 | 110 @ 22.81p |
You are here: research